AINDEX
Markets

McKesson Corporation (MCK)

MCKNYSEOther Pharmaceuticals

$1,082.59

+23.22 (+2.19%) today

At the close, Nov 10, 4:00 PM ET. After hours $1,082.59 -0.12%

+2.19% 1D
Market cap
$125.15bn
P/E
25.4
EPS, last 4 quarters
$42.64
Dividend yield
–
Day range
$1,059.00 to $1,086.94
52-week range
$723.68 to $1,121.50
Average volume
1.13m
Previous close
$1,059.37

Analysts

14 covering

Buy11 buy, 3 hold, 0 sell

Targets a year out average $1,130.85, +4.5% from here

$913.00now $1,082.59$1,260.00

Earnings

next estimate $10.85

Next report

Dec 2025

+0.3%

Mar 2026

+1.1%

Jun 2026

+5.2%

Sep 2026

+9.3%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$106.16bn$96.30bn$105.38bn$110.96bn
Gross profit$3.69bn$4.04bn$3.69bn$3.96bn
Operating income$1.62bn$2.15bn$1.32bn$1.60bn
Net income$1.19bn$1.68bn$614.00m$1.22bn

Last four quarters: revenue $418.79bn, margin 1.1%, free cash flow $7.11bn

News

8 latest

The company

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Stories & Insights.

Sector
Health Care
Industry
Other Pharmaceuticals
Exchange
NYSE
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.